Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin and Lyxumia; Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia, congenital hyperinsulinism, and post bariatric surgery hypoglycemia; and Dasiglucagon dual-hormone artificial pancreas for automated diabetes management. The company’s pipeline includes Dasiglucagon that is in Phase III clinical trials for congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; Alexion Pharmaceuticals, Inc.; and Beta Bionics, Inc. The company was incorporated in 1998 and is headquartered in Copenhagen, Denmark.
| Average | 235.60 (+12.41% Upside) |
| High | 284.4114 |
| Low | 171 |
| Price | 209.6 |
| No. of Analysts | 9 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 104.70 | 105.10 | 101.70 | 0.00 | 0.00% | 0.00 | London | |||
| 90.25 | 90.25 | 86.75 | +3.32 | +3.82% | 39.90M | London | |||
| 1,080.00 | 1,080.00 | 1,047.00 | 0.00 | 0.00% | 0.00 | London | |||
| 944.00 | 959.00 | 932.50 | +5.50 | +0.59% | 485.40K | London | |||
| 261.90 | 262.30 | 256.00 | +4.50 | +1.75% | 21.55M | London | |||
| 201.70 | 204.30 | 197.85 | +1.30 | +0.65% | 12.46M | London | |||
| 64.50 | 67.48 | 63.00 | -3.62 | -5.31% | 4.48M | London | |||
| 104.90 | 106.35 | 103.30 | +0.25 | +0.24% | 8.75M | London | |||
| 787.80 | 800.00 | 776.40 | -8.60 | -1.08% | 1.48M | London | |||
| 1,424.00 | 1,427.60 | 1,401.20 | +8.60 | +0.61% | 6.06M | London | |||
| 2,100.00 | 2,104.00 | 2,074.00 | -6.00 | -0.28% | 2.66M | London | |||
| 145.00 | 145.00 | 145.00 | -1.00 | -0.68% | 72.15K | London | |||
| 228.50 | 230.50 | 226.90 | -0.20 | -0.09% | 13.66M | London | |||
| 105.00 | 107.40 | 101.20 | +2.00 | +1.94% | 1.19M | London | |||
| 64.80 | 64.60 | 64.60 | +0.40 | +0.62% | 192.30K | London |